ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
SeaStar Medical Holding Corporation

SeaStar Medical Holding Corporation (ICU)

1,65
0,00
(0,00%)
Fermé 24 Janvier 10:00PM
1,57
0,00
( 0,00% )
Avant marché: 10:04AM

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

Dernier
1,57
Prix Achat
1,57
Prix Vente
1,79
Volume échangé
-
0,00 Fourchette du Jour 0,00
1,60 Plage de 52 semaines 42,9225
Cap du marché
Clôture Veille
1,57
Ouverture
-
Dernière Transaction
Dernière heure de transaction
-
Volume financier
-
VWAP
-
Volume moyen (3 m)
267 672
Actions en circulation
4 463 148
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,27
Bénéfice par action (BPA)
-5,88
Chiffre d'affairess
-
Bénéfice net
-26,23M

À propos de SeaStar Medical Holding Corporation

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs.

Secteur
Surgical,med Instr,apparatus
Industrie
Blank Checks
Siège social
Wilmington, Delaware, USA
Fondé
2022
SeaStar Medical Holding Corporation est coté dans le secteur Surgical,med Instr,apparatus de la NASDAQ avec le ticker ICU. Le dernier cours de clôture d'SeaStar Medical était de US$1,57. Au cours de la dernière année, les actions de SeaStar Medical ont été négociées dans une fourchette de prix de US$ 1,60 à US$ 42,9225.

SeaStar Medical compte actuellement 4 463 148 actions en circulation. La capitalisation boursière d'SeaStar Medical est de US$7,01 million. SeaStar Medical a un ratio cours/bénéfice (ratio PE) de -0.27.

ICU Dernières nouvelles

SeaStar Medical Activates 15th Site for its Adult Acute Kidney Injury Pivotal Trial

DENVER, Jan. 22, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences...

FDA Approves Feasibility Study with SeaStar Medical’s Selective Cytopheretic Device in Adults with Cardiorenal Syndrome

Study to be conducted under $3.6 million NIH grant  DENVER, Jan. 13, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company...

SeaStar Medical Begins Shipping QUELIMMUNE to a Fourth Hospital Customer

DENVER, Jan. 08, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences...

SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal Trial

DENVER, Dec. 23, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences...

SeaStar Medical Projects Multibillion-Dollar Market Potential for its Selective Cytopheretic Device in Initial Target Indications

U.S. total addressable market for five initial indications is $25 to $33 billion REMINDER: Business Update Conference Call begins at 4:30 p.m. Eastern time today DENVER , Dec. 11, 2024 (GLOBE...

SeaStar Medical to Hold Business Update Conference Call on December 11, 2024

DENVER, Dec. 04, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences...

SeaStar Medical Activates Sentara Norfolk General Hospital and Provides Enrollment Update in Adult AKI Pivotal Trial

DENVER, Dec. 03, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences...

SeaStar Medical to Present at Noble Capital Markets’ NobleCon20 on December 4, 2024

DENVER, Nov. 26, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences...

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Support SeaStar Medical’s Proposals to Ratify the Issuance of Shares and to Reduce the Number of Authorized Shares

SeaStar Medical urges stockholders to vote FOR all proxy proposals prior to the Special Meeting of Stockholders to be held November 26, 2024 DENVER, Nov. 22, 2024 (GLOBE NEWSWIRE) -- SeaStar...

SeaStar Medical Reaches Milestone of 100th QUELIMMUNE Commercial Device as Shipments Begin to its Third Hospital Customer

DENVER, Nov. 15, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.18-10.28571428571.751.841.61672171.70700426CS
4-0.535-25.41567695962.1052.181.61988221.88668132CS
12-1.57-503.143.18931.62676722.17579644CS
26-5.48-77.73049645397.059.55991.61640033.25477454CS
52-20.1375-92.767476678621.707542.92251.6185911018.84073231CS
156-279.18-99.4407836153280.753051.6302668319.82975763CS
260-279.18-99.4407836153280.753051.6302668319.82975763CS

ICU - Frequently Asked Questions (FAQ)

What is the current SeaStar Medical share price?
The current share price of SeaStar Medical is US$ 1,57
How many SeaStar Medical shares are in issue?
SeaStar Medical has 4 463 148 shares in issue
What is the market cap of SeaStar Medical?
The market capitalisation of SeaStar Medical is USD 7,01M
What is the 1 year trading range for SeaStar Medical share price?
SeaStar Medical has traded in the range of US$ 1,60 to US$ 42,9225 during the past year
What is the PE ratio of SeaStar Medical?
The price to earnings ratio of SeaStar Medical is -0,27
What is the reporting currency for SeaStar Medical?
SeaStar Medical reports financial results in USD
What is the latest annual profit for SeaStar Medical?
The latest annual profit of SeaStar Medical is USD -26,23M
What is the registered address of SeaStar Medical?
The registered address for SeaStar Medical is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the SeaStar Medical website address?
The website address for SeaStar Medical is seastarmedical.com
Which industry sector does SeaStar Medical operate in?
SeaStar Medical operates in the BLANK CHECKS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
STBXStarBox Group Holdings Ltd
US$ 0,9267
(81,67%)
3,13M
EVAXEvaxion Biotech AS
US$ 5,41
(48,63%)
523,89k
DWTXDogwood Therapeutics Inc
US$ 19,32
(44,72%)
690,24k
FSEAFirst Seacoast Bancorp Inc
US$ 14,00
(38,62%)
16
NVNINVNI Group Ltd
US$ 1,94
(30,20%)
625,13k
HYZNHyzon Motors Inc
US$ 0,436
(-43,52%)
13,07k
MDXGMiMedx Group Inc
US$ 5,11
(-43,41%)
50
IROQIF Bancorp Inc
US$ 14,01
(-41,89%)
3
LRFCLogan Ridge Finance Corporation
US$ 14,01
(-41,65%)
1
CNTACentessa Pharmaceuticals PLC
US$ 10,00
(-38,57%)
203
BTAIBioXcel Therapeutics Inc
US$ 0,4804
(26,49%)
8,89M
STBXStarBox Group Holdings Ltd
US$ 0,9267
(81,67%)
3,13M
ACONAclarion Inc
US$ 0,0485
(12,27%)
2,84M
SHViShares Short Treasury Bond ETF
US$ 110,41
(0,03%)
2,46M
HEPAHepion Pharmaceuticals Inc
US$ 0,2175
(8,75%)
1,48M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock